MAIT cells are associated with responsiveness to neoadjuvant immunotherapy in COPD‐associated NSCLC

Documenti analoghi

• Deep learning model for predicting immunotherapy response in patients with advanced NSCLC
  di: Mary Beth Nierengarten
  Pubblicazione: (2025)
• Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective
  di: Fuqiang Dai, et al.
  Pubblicazione: (2024)
• PET–CT for visualizing the pathophysiology of COPD in patients with early‐stage NSCLC
  di: Haruki Kobayashi, et al.
  Pubblicazione: (2024)
• Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy
  di: Guangyu Bai, et al.
  Pubblicazione: (2024)
• Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
  di: Xiaofeng Duan, et al.
  Pubblicazione: (2024)